Navigation Links
Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
Date:1/25/2013

ported with KAZANO include upper respiratory tract infection, nasopharyngitis, diarrhea, hypertension, headache, back pain and urinary tract infection.

Takeda is committed to providing type 2 diabetes patients with treatment options that help address their needs, and is planning to commercially launch NESINA, OSENI and KAZANO in the summer of 2013.

Takeda's consolidated financial statements for the 2012 fiscal year will not be impacted by the FDA approvals.

Clinical Trial Program
U.S.-based Takeda Global Research & Development Center, Inc. conducted worldwide placebo- and active-controlled clinical trials of NESINA involving more than 13,000 patients. The safety and efficacy of NESINA was studied as a once-daily monotherapy and in combination with several other classes of anti-diabetic medications, including biguanides, TZDs, insulin and sulfonylureas. In these studies, NESINA 25 mg, taken once daily, demonstrated clinically meaningful and statistically significant improvements in hemoglobin A1C compared to placebo.

Of the total number of patients included in the NESINA clinical trial program, more than 3,000 were included in the studies used to support the FDA approval of OSENI, and more than 4,000 were included in those to support the FDA approval of KAZANO. Study results indicated that alogliptin co-administered with either pioglitazone or metformin HCl produced significant improvements in glycemic control as compared to the respective monotherapies.

About Type 2 Diabetes
Type 2 diabetes is the most common form of diabetes affecting millions of people globally. In fact, more than 23 million people in the U.S. alone currently live with the disease. Type 2 diabetes is a progressive and chronic condition and patients should work with a health care professional to manage and monitor their disease. In addition to diet and exercise, patients often need to take multiple medications in order to help them manage their blood
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
2. Takedas Deerfield Campus Ranked Among Chicagos Top 100 Workplaces in 2012
3. Takeda Completes its Russian Pharmaceutical Manufacturing Facility
4. Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
5. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
6. Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil
7. IntelliCell BioSciences Receives Notice of Allowance for its US Patent for "Ultrasonic Cavitation of Adipose Tissue to Produce Stromal Vascular Fraction Regenerative Cells"
8. Zimmer Receives FDA Clearance for Revolutionary New Surgical Guidance Technology
9. American Capital Receives $60 Million From The Sale Of Lifoam Holdings And Generates An 11% Return On Its Investment
10. PrimeMail, Prime Therapeutics mail-service pharmacy, receives URAC Reaccreditation
11. Brolex C SAFE cesarean section safety device receives top scores, rated a MUST HAVE medical device for performing c/sections.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... July 28, 2015 Codman Neuro*, part of ... a new platform of embolic coils for the treatment ... designed to improve microcatheter stability and provide an optimized ... made here at the Society of NeuroInterventional Surgery (SNIS) ... of framing, filling and finishing coils used during a ...
(Date:7/28/2015)... 28, 2015 Amgen (NASDAQ: AMGN ) ... $0.79 per share dividend for the third quarter of ... 2015, to all stockholders of record as of the ... About Amgen Amgen is committed to unlocking the ... by discovering, developing, manufacturing and delivering innovative human therapeutics. ...
(Date:7/28/2015)... 2015  Insulet Corporation (NASDAQ: PODD ), the ... ® Insulin Management System, today announced that Dr. ... Board of Directors. Dr. Hopfield brings more ... Insulet Board. She currently serves as the Vice Chair ... world,s largest diabetes research center, diabetes clinic, and provider ...
Breaking Medicine Technology:Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 2Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 3Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 4Amgen Announces 2015 Third Quarter Dividend 2Amgen Announces 2015 Third Quarter Dividend 3Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 2Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 3
... of Body Consistent with Overall PASI ... Response in REMICADE-Treated Patients, SAN ANTONIO, Feb. ... trials showed patients with moderate,to severe plaque psoriasis receiving REMICADE(R) ... of the four body regions,(head, trunk, lower and upper extremities) ...
... PRINCETON, N.J., Feb. 4 Pharmacopeia (Nasdaq:,PCOP), an ... small,molecule therapeutics, today announced that Dr. Leslie J. ... corporate presentation at the,BIO CEO & Investor Conference ... at The Waldorf-Astoria Hotel in New York City., ...
Cached Medicine Technology:REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 2REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 3REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 4REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 5REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 6REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 7REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 8REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 9REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 10Pharmacopeia to Present at BIO CEO & Investor Conference 2008 2Pharmacopeia to Present at BIO CEO & Investor Conference 2008 3
(Date:7/28/2015)... ... 2015 , ... Santa Rosa’s The Press Democrat announced its annual report of the very best ... Dr. Heather Furnas took the top spot as the Best Cosmetic Surgeons in Sonoma ... proud to be bestowed such a prestigious title. , The Press Democrat was ...
(Date:7/28/2015)... ... ... Mindful Her, a unique women’s wellness and lifestyle event designed to inspire and ... the next level, announced today an influential line-up of inspiring speakers, including Mallika Chopra, ... an Orange County based non-profit that works locally and globally to help girls become ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... the Lost and Found, a breakthrough technological invention. It is a wearable ... the consumer electronic industry reached a record high of $211.3 billion in 2014," ...
(Date:7/28/2015)... ... ... 2016, the number of smartphones worldwide will surpass 2 billion. This means that brands ... customer loyalty. However, capitalizing on this is not always obvious. Companies that do not, ... , The Open Mobile Summit 2015 is an influential gathering of mobile visionaries from ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... with 1 in 68 children currently affected with the disorder. For these families, ... the road to recovery is extremely daunting. That’s where Talk About Curing Autism ...
Breaking Medicine News(10 mins):Health News:Dr. Canales and Dr. Furnas Honored as Sonoma County’s Best Cosmetic Surgeons 2Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 2Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 3Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 2Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 3Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 4Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 5Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 2Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 3Health News:National TACA Autism Conference Offers Hope and Help to Families Affected by Autism 2
... cell research and manufacturing, announced today the appointment of Carl Bullen ... manufacturing systems and procedures at Stemedica,s San Diego-based manufacturing facility that ... , ... San Diego, CA (PRWEB) March 5, 2009 ...
... minimally-invasive (no-scalpel/no-stitch) hair transplant surgery benefits patients with better results, ... , ... Boca Raton, FL (PRWEB) ... available in the U.S. can dramatically improve hair transplant surgery ...
... CHARENTON-LE-PONT, France, March 5 , - 2008: Solid ... the Currency Effect, - Contribution Margin at 17.9%, ... Excluding the Currency, Effect), ... , The Board of Directors of Essilor ...
... Wake Forest University School of Medicine identifies the presence ... likely it is that elderly, hospitalized patients who receive ... heart attack. , An advance copy of the study ... Neurology , the official publication of the European Neurological ...
... is a statement by Matthew L. Myers, President, ... Energy and Commerce Committee today set Congress on ... reduce tobacco use by approving legislation granting the ... products. Today,s 39-13 vote underscores the broad, ...
... March 4 National Center for Creative Aging (NCCA) will ... programs as a way to engage people with dementia. The ... Symposium," will be held in Washington, D.C. on March ... said, "Cases of dementia and Alzheimer,s disease increase with age, ...
Cached Medicine News:Health News:Stemedica Announces the Appointment of Carl Bullen as Director of Manufacturing 2Health News:Stemedica Announces the Appointment of Carl Bullen as Director of Manufacturing 3Health News:New NeoGraft™ Device Improves Hair Transplants 2Health News:New NeoGraft™ Device Improves Hair Transplants 3Health News:Essilor : 2008 Results 2Health News:Essilor : 2008 Results 3Health News:Essilor : 2008 Results 4Health News:Essilor : 2008 Results 5Health News:Essilor : 2008 Results 6Health News:Essilor : 2008 Results 7Health News:Essilor : 2008 Results 8Health News:Essilor : 2008 Results 9Health News:Essilor : 2008 Results 10Health News:Essilor : 2008 Results 11Health News:Essilor : 2008 Results 12Health News:Essilor : 2008 Results 13Health News:Essilor : 2008 Results 14Health News:Essilor : 2008 Results 15Health News:Number of cardiovascular risk factors could determine safety of intravenous gammaglobulin treatment 2Health News:Number of cardiovascular risk factors could determine safety of intravenous gammaglobulin treatment 3Health News:House Committee Vote Sets Congress on Course for Historic Regulation of Tobacco Products 2Health News:House Committee Vote Sets Congress on Course for Historic Regulation of Tobacco Products 3Health News:National Center for Creative Aging Presents 'Creativity Matters' Symposium on Health, Wellness, and the Arts 2Health News:National Center for Creative Aging Presents 'Creativity Matters' Symposium on Health, Wellness, and the Arts 3Health News:National Center for Creative Aging Presents 'Creativity Matters' Symposium on Health, Wellness, and the Arts 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: